electron beams antibiotics mixed- tissue tumors benign tumor alkylating agents brachytherapy fractionation antimitotics combination chemotheraphy dedifferentiation microscopic description of tumors encapsulated mucinous mesenchymal genetic screening modality mutation infiltrative mitosis gross description of tumors apoptosis invasive adjuvant chemotherapy external beam irradiation chemotherapy grading of tumors irradiation linear accelerator molecularly targeted therapy DNA differentiation fields carcinogens malignant tumor metastasis gray morbidity carcinoma immunotheraphy anaplasia electron beams antibiotics mixed- tissue tumors benign tumor alkylating agents brachytherapy fractionation antimitotics combination chemotheraphy dedifferentiation microscopic description of tumors encapsulated mucinous mesenchymal genetic screening modality mutation infiltrative mitosis gross description of tumors apoptosis invasive adjuvant chemotherapy external beam irradiation chemotherapy grading of tumors irradiation linear accelerator molecularly targeted therapy DNA differentiation fields carcinogens malignant tumor metastasis gray morbidity carcinoma immunotheraphy anaplasia
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
electron beams
antibiotics
mixed-tissue tumors
benign tumor
alkylating agents
brachytherapy
fractionation
antimitotics
combination chemotheraphy
dedifferentiation
microscopic description of tumors
encapsulated
mucinous
mesenchymal
genetic screening
modality
mutation
infiltrative
mitosis
gross description of tumors
apoptosis
invasive
adjuvant chemotherapy
external beam irradiation
chemotherapy
grading of tumors
irradiation
linear accelerator
molecularly targeted therapy
DNA
differentiation
fields
carcinogens
malignant tumor
metastasis
gray
morbidity
carcinoma
immunotheraphy
anaplasia